Form 4: Hims & Hers Health PAO Irene Becklund Reports Stock Transactions

Irene Becklund, PAO of Hims & Hers Health, reports the vesting and sale of Class A Common Stock and Restricted Stock Units.

Summary

• On March 14, 2025, Irene Becklund, the PAO of Hims & Hers Health, Inc., engaged in transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• 24,097 shares of Class A Common Stock were acquired through the vesting of RSUs.
• 7,813 shares were disposed of to cover tax withholding obligations at a price of $33.14 per share.
• On March 18, 2025, 8,277 shares of Class A Common Stock were sold at a price of $34.31 per share.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 7, 2024.
• Various tranches of RSUs vested, with the underlying shares being Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Hims & Hers Health.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• Similar filings are common among executives at companies like Teladoc Health and GoodRx, which operate in the telehealth space.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the insider selling activity.
• The impact is likely minimal given the pre-planned nature of the sales under Rule 10b5-1.

Key Dates